Dr. I.M. Bennani-Baiti currently serves as the Executive Editor of Clinical Cancer Epigenetics. Dr. Bennani-Baiti has longstanding interests in pediatric cancer, epigenetics, epigenomics, chemistry, and biomathematics. He has extensive experience in reviewing and editing research papers, serving since 2009 as the Executive Editor or Editor to 9 biomedical journals, and as a Reviewer to more than a dozen other journals. A University of Pennsylvania School of Medicine Human Genetics Fellow, he is also a Howard Hughes scholar who served on the Faculty of St. Louis University School of Medicine under the chairmanship of Dr. William Sly, a member of the National Academy of Sciences, USA, who characterized the syndrome named after him. Other tenures include the Memorial Sloan-Kettering Cancer Center in New York alongside Dr. Mark Ptashne, Lasker Award laureate and member of the National Academy of Sciences, USA, first under the leadership of Dr. Paul Marks, member of the National Academy of Sciences, USA, and later Dr. Harold Varmus, former director of the National Institute of Health (NIH) and of the National Cancer Institute (NCI), Lasker Award and Nobel Prize laureate, and member of the National Academy of Sciences, USA. Dr. Bennani-Baiti is a member of the Society for Mathematical Biology, the American Chemical Society, and the AACR Pediatric Cancer Working Group. He is also a member of the New York Academy of Sciences, USA, and President of the Cancer Epigenetics Society.